Lustig A
Pharmacy Department, Barzilai Medical Center, Ashkelon, Israel.
Eur J Clin Pharmacol. 1994;47(2):203-6. doi: 10.1007/BF00194973.
A new device for IV admixtures has been developed in Israel, the Vialink minibag. It consists of a partly filled minibag, attached by rubber tubing to a sterile receptable into which various types of vials containing drugs can be firmly inserted. Time and motion studies were conducted to determine the time and cost associated with the preparation, dispensing and administration of reconstituted parenteral antibiotics via CIVAS (within minibags or Vialink bags) and preparation by nurses in wards in minibags. CIVAS with minibags was least expensive, followed by Vialink minibags. Self preparation on the ward by nurses was found to be the most expensive system. Only 55% of all IV admixtures can be prepared by the Vialink system. As only one hospital in Israel has CIVAS, the study provides a solid justification for implementing pharmacy intravenous admixture services in all Israeli hospitals. The advantages and disadvantages of each method are discussed. CIVAS (minibags and Vialink) permits the individualised preparation of sterile admixtures for each patient and provides advantages in terms of efficiency, economy and prevention of errors.
以色列研发出了一种用于静脉内混合液的新设备——Vialink微型袋。它由一个部分装满的微型袋组成，通过橡胶管连接到一个无菌容器，各种装有药物的小瓶可以牢固地插入该容器中。进行了时间与动作研究，以确定通过集中静脉药物配置服务（在微型袋或Vialink袋内）配制、分发和使用复溶后的胃肠外抗生素以及由病房护士在微型袋中配制的时间和成本。使用微型袋的集中静脉药物配置服务成本最低，其次是Vialink微型袋。发现护士在病房自行配制是最昂贵的系统。Vialink系统只能配制所有静脉内混合液的55%。由于以色列只有一家医院拥有集中静脉药物配置服务，该研究为在所有以色列医院实施药房静脉内混合液服务提供了有力的理由。讨论了每种方法的优缺点。集中静脉药物配置服务（微型袋和Vialink）允许为每个患者个性化配制无菌混合液，并在效率、经济性和预防差错方面具有优势。
